Monday 19 October 2026
Export VJET’s income statement to Excel — free account
Flyte Aviation, Inc.
VJET Healthcare Medical Devices
Flyte Aviation, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $819,000.00, up 95.0% from fiscal 2024. In the quarter to June 2026, revenue grew 380.7%, EPS grew 87.3%, free cash flow fell 26.7% and total debt rose 160.0%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.
0.84
0.14
−14.29%
Follow VJET
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 4 | 3 | 1 | 2 | 3 | 4 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(30.65) | (15.46) | (19.48) | (16.90) | (9.75) | (2.30) | 7.65 | 14,265,259.50 | — | — |
P/S ratio |
24.15 | 34.97 | 49.69 | 3,407.40 | 4,510.43 | 545.06 | 37.28 | 27,852,635.05 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(73.28) | (36.02) | (43.63) | (45.59) | (31.37) | (16.35) | (9.94) | 9.68 | (15.20) | (13.29) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(4.90) | (4.34) | — | — | — | — | — | (2.25) | (6.98) | — |
P/Operating CF |
(13.08) | (5.13) | (11.63) | (21.40) | (18.16) | (15.00) | (28.04) | (20,749,367.48) | (108,830,132.73) | (108,830,132.73) |
P/B ratio |
2.97 | 1.25 | 1.04 | 6.99 | 7.59 | 6.68 | 8.10 | 2,612,606.81 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 6.99 | 7.59 | 6.68 | 8.10 | 2,612,606.81 | 0.00 | 0.00 |
EV/Sales |
28.12 | 32.48 | 42.43 | 2,678.56 | 3,953.96 | 459.88 | 33.11 | 27,852,624.91 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.78) | (1.47) | (0.91) | (2.26) | (3.29) | (4.21) | (7.19) | (9,416,137.56) | (33,542,301.33) | (33,542,301.33) |
EV/FCF |
(2.77) | (1.46) | (0.91) | (2.26) | (3.33) | (4.20) | (7.13) | (9,129,066.21) | (31,363,839.83) | (31,363,839.83) |
Quick Ratio |
0.06 | 1.32 | 1.50 | 2.09 | 2.80 | 3.08 | 4.60 | 11.03 | 3.32 | 1.59 |
Current Ratio |
0.10 | 1.48 | 1.68 | 2.22 | 3.17 | 3.56 | 5.28 | 11.64 | 3.81 | 1.96 |
Net Debt/EBITDA |
(0.16) | 0.14 | 0.05 | 0.60 | 0.47 | 0.67 | 0.54 | 2.08 | 0.47 | 0.93 |
Debt/Assets |
19.41% | 5.62% | 0.00% | 0.00% | 9.41% | 5.51% | 1.27% | 1.15% | 0.56% | 1.83% |
Debt/Equity |
0.46 | 0.13 | 0.00 | 0.00 | 0.14 | 0.09 | 0.02 | 0.01 | (0.01) | (0.28) |
Asset Turnover |
0.04 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.12 | 0.15 | 0.69 | 0.70 |
Operating CF/Net income |
0.48 | 0.43 | 0.29 | 0.84 | 1.10 | 0.79 | 0.58 | 0.60 | 0.31 | 0.45 |
Capex/Depreciation |
(0.01) | (0.03) | (0.04) | 0.05 | 0.21 | (0.03) | (0.15) | (0.93) | (2.51) | 0.00 |
Interest Coverage |
(75.24) | (123.55) | — | — | — | (274.43) | (230.92) | (2,225.71) | (4,440.00) | (2,798.67) |
| (186.69%) | (132.33%) | (468.74%) | (234.29%) | (144.00%) | (132.77%) | (114.08%) | (104.36%) | 444.40% | 105.12% | |
| (78.77%) | (74.53%) | (300.06%) | (141.84%) | (92.03%) | (93.00%) | (96.44%) | (72.29%) | (207.64%) | (49.11%) | |
ROIC |
(137.06%) | (67.28%) | (276.97%) | 0.00% | (3,003.49%) | 0.00% | (1,152.39%) | (601.08%) | 0.00% | 0.00% |
Return on Tangible Assets |
497.63% | (1,890.81%) | (4,057.53%) | (290.12%) | (185.59%) | (161.02%) | (166.37%) | (45.31%) | (207.34%) | (135.37%) |
Average Days of Receivables |
69.08 | 60.83 | 113.13 | 0.00 | 348.41 | 33.82 | 39.85 | 77.00 | 32.15 | 24.00 |
Research and Development Expense of Revenue |
105.25% | 64.76% | 107.47% | 45,657.14% | 55,695.45% | 3,457.53% | 62.93% | 44.37% | 76.97% | 28.70% |
Selling, General and Administrative Expense of Revenue |
1,474.36% | 2,702.14% | 3,873.76% | 116,071.43% | 70,340.91% | 9,472.20% | 716.06% | 486.42% | 254.63% | 89.04% |
Intangible Assets out of Total Assets |
0.96 | 0.87 | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
41.27% | 12.86% | 275.34% | 3,192.86% | 10,168.18% | 1,576.06% | 327.03% | 235.38% | 216.46% | 0.00% |
Graham Net Nets |
(0.45) | (0.87) | (0.24) | 0.14 | 0.09 | 0.11 | 0.09 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(101.90%) | (113.31%) | (321.09%) | (40.76%) | (36.30%) | (42.57%) | (6.38%) | 0.00% | (8.66%) | (8.66%) |
Free Cash Flow Yield |
(42.04%) | (63.57%) | (94.22%) | (34.76%) | (26.31%) | (20.10%) | (12.46%) | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.76 | 2.44 | 15.29 | 2.59 | 44.00 | 1,295.00 | 71,990.00 | 0.68 | 0.78 | 11.77 |
Operating CF per Share |
(7.68) | (53.96) | (713.46) | (4,179.26) | (55,250.00) | (141,520.00) | (331,730.00) | (2.01) | (0.73) | (3.72) |
Capex per Share |
(0.02) | (0.39) | (2.63) | 3.89 | 658.00 | (335.00) | (2,680.00) | (0.06) | (0.07) | 0.00 |
Free Cash Flow per Share |
(7.69) | (54.35) | (716.09) | (4,175.37) | (54,592.00) | (141,855.00) | (334,410.00) | (2.07) | (0.80) | (3.72) |
Cash per Share |
0.08 | 16.72 | 123.36 | 2,936.85 | 30,090.00 | 119,530.00 | 305,770.00 | 6.97 | 1.09 | 7.72 |
Shareholders Equity per Share |
6.15 | 68.43 | 733.32 | 1,714.81 | 27,346.00 | 105,735.00 | 331,500.00 | 7.23 | (1.01) | (0.75) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.15 | 68.43 | 733.32 | 1,714.81 | 27,346.00 | 105,735.00 | 331,500.00 | 7.23 | (1.01) | (0.75) |
Free Cash Flow |
(8.31) | (9.34) | (20.69) | (22.55) | (27.30) | (28.37) | (33.44) | (19.09) | (6.07) | (1.89) |
Working Capital |
(3.52) | 1.06 | 1.69 | 9.26 | 11.70 | 19.86 | 29.19 | 63.28 | 7.41 | 2.60 |
Capital Expenditures |
(0.02) | (0.07) | (0.08) | 0.02 | 0.33 | (0.07) | (0.27) | (0.58) | (0.55) | (0.21) |
Net Current Asset Value |
(8.82) | (12.72) | (5.38) | 9.26 | 9.72 | 15.33 | 25.07 | 61.90 | (8.84) | (0.91) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.16 | 0.17 | (1.50) | (14.95) | 0.26 | 0.04 | 0.09 | 0.09 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
33.05 | 23.18 | 29.64 | 0.00 | 0.87 | 0.94 | 0.35 | 0.13 | 0.19 | 0.19 |
Cash ROIC |
(84.68%) | (57.67%) | (83.59%) | (89.76%) | (88.91%) | (60.50%) | (52.02%) | (14.48%) | (886.13%) | (51.70%) |
Accounts Receivable Turnover |
7.28 | 4.06 | 5.59 | 0.00 | 0.98 | 0.64 | 6.84 | 6.81 | 12.90 | 13.13 |
Accounts Payable Turnover |
0.07 | 0.12 | 0.11 | 0.30 | 2.14 | 2.17 | 6.66 | 5.42 | 9.27 | 6.98 |
Inventory Turnover |
1.06 | 1.09 | 0.06 | 0.00 | 1.67 | 1.19 | 3.63 | 2.55 | 4.03 | 3.04 |
Average Days of Payables |
8,644.13 | 1,998.81 | 5,645.33 | 208.57 | 231.17 | 79.15 | 63.18 | 97.63 | 37.33 | 55.02 |
Days of Inventory on Hand |
498.25 | 286.79 | 535.33 | 0.00 | 230.70 | 147.38 | 114.53 | 181.98 | 104.81 | 101.20 |
Average Receivables |
0.11 | 0.10 | 0.08 | — | 0.02 | 0.41 | 1.05 | 0.92 | 0.46 | 0.46 |
Average Payables |
0.86 | 0.35 | 0.28 | 0.54 | 0.73 | 1.00 | 1.33 | 0.78 | 0.45 | 0.45 |
Average Inventory |
0.06 | 0.04 | 0.52 | — | 0.93 | 1.83 | 2.44 | 1.65 | 1.03 | 1.03 |
Average Assets |
21.82 | 29.25 | 23.79 | 18.94 | 27.24 | 38.76 | 59.06 | 42.65 | 8.56 | 8.56 |
Average Common Equity |
9.20 | 16.48 | 15.23 | 11.47 | 17.41 | 27.15 | 49.93 | 29.55 | (4.00) | (4.00) |
Columns are period end dates